Study of Combined Fulvestrant and Everolimus in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure
Clinical trial NCT00570921 · COMPLETED
Trial details
- NCT number
- NCT00570921
- Sponsor
- Mara Chambers
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2013-02-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.